Clinical Trial Update: A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH [Phase 3]

View source ↗

Summary

This document reports a Phase III clinical trial evaluating AZD0780's effect on LDL-C in patients with heterozygous familial hypercholesterolemia, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterozygous Familial Hypercholesterolemia

Drugs mentioned

• AZD0780

Snippet

Sponsor: AstraZeneca | Conditions: Heterozygous Familial Hypercholesterolaemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING